CWG
FOMX

C WorldWide Group’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

C WorldWide Group’s Portfolio FOMX Stock Details FOMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-442,884
Closed -$1.66M – 120
2019
Q1 		$1.66M Hold
442,884
– – 0.02% 98
2018
Q4 		$1.59M Sell
442,884
-157,116
-26% -$683K 0.02% 88
2018
Q3 		$3.44M Buy
+600,000
New +$3.43M 0.04% 78

Other funds holding FOMX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

C WorldWide Group's FOMX Position: Q2 2019 in Review

C WorldWide Group sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q2 2019, closing a stake of 442,884 shares — an estimated $1.66M sold.

C WorldWide Group first reported a position in FOMX in Q3 2018 and held it in 3 quarters. The position peaked at $3.44M in Q3 2018. 58 funds tracked by Wall St. Rank hold FOMX as of Q2 2019.

  • C WorldWide Group reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q2 2019 after selling out during the quarter.
  • C WorldWide Group sold 442,884 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q2 2019, an estimated $1.66M.
  • C WorldWide Group first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q3 2018 and held it in 3 quarters.
  • C WorldWide Group's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $3.44M in Q3 2018.
  • 58 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q2 2019.

Based on C WorldWide Group's 13F filing for Q2 2019, filed 2 Aug 2019.